about
Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals?Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategiesNestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cellsThe cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials.PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5'-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells.[Effects of thyroid autoimmunity on pregnancy outcomes in euthyroid women receiving in vitro fertilization: a meta-analysis].Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients.Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trialThe effects of pioglitazone on biochemical markers of bone turnover in the patients with type 2 diabetes.Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease.Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathwayCombination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration.Type 1 diabetes mellitus care and education in China: The 3C study of coverage, cost, and care in Beijing and Shantou.GLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway.Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.Ghrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway.Uric acid, renal function and risk of hypoglycaemia in Chinese type 2 diabetes patients.Non-linear associations of risk factors with mild hypoglycemia among Chinese patients with type 2 diabetes.FOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expressionHomocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.[Association of obesity with diabetes and its underlying mechanism].Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase.Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells.Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial.Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells.Incretin-based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus.Liraglutide restores angiogenesis in palmitate-impaired human endothelial cells through PI3K/Akt-Foxo1-GTPCH1 pathway.Monoclonal side population progenitors isolated from human fetal pancreas.[Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus].Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes.Infarcted cardiac microenvironment may hinder cardiac lineage differentiation of human embryonic stem cells.
P50
Q33970970-86C0B5DD-8F89-453F-9A39-1A483122F802Q34720302-59A66957-DB09-4562-8F9A-30ACFB400E64Q34951717-1E314EA8-11E4-4DA4-82B6-B4A6A37E101CQ35010291-5683FB14-6B81-4C8F-B815-F8A1326AFD02Q35017639-25E83E74-2B8A-45DD-9599-78417725294FQ35608768-9D39CC34-F261-4095-9E78-3C7FAE38A70AQ35916206-98EB44C7-36FE-426A-9B22-2A6B0AAD98A0Q36760949-F4B34C2D-92E4-4AB4-AFF4-778939F0F129Q36794427-72285AF3-768F-4387-8F88-FE31C5020A66Q36969616-218EFD84-710A-41EE-A930-15A910C00499Q37071231-EEE906C6-E1CB-4E74-AF26-A42342C1964EQ37386378-785417D5-4678-4E8F-8F0C-635862063FE6Q37420086-334BAADF-7890-4095-8CE4-58224E8092FCQ37618348-4747B173-14DF-4A27-BB44-39F77D9CC465Q38106411-B5C22BA4-4634-41C5-B7E1-C30AD7092D0AQ38711860-0FA26759-56D2-4E31-AFEE-5A7BC61CACF8Q38788198-0C7EC1AB-5394-455A-8CEF-E02BDE780A61Q38972726-CD8F6672-4499-46C5-A022-AB5C5F1AC9D0Q38997962-A805DA81-F846-47DB-89FF-2929F38A42B7Q39014390-CEC61149-0C77-4391-8408-7587F2D63637Q39312387-704C2EE5-DB14-4881-82B8-CD82BAEB4244Q40493359-5DA093C4-0FB6-44BF-8253-E4B0BF0DF227Q40947425-B8DBEE4D-6AB8-4345-95F7-238F26D85607Q41335606-943619FB-E1B9-442B-80AC-EB5D2C5740BDQ42880621-326602A0-B455-4874-A8AD-A520FCEC1308Q44423262-3B0DC4DA-A0F5-4A07-AB51-2B0808BD97B1Q46543541-6F4F382A-0585-4213-9C72-CDDBF0BAFE0BQ46564566-0DD1D04C-B165-4545-A58B-0F6089C7ACA8Q46644467-7A2FEF27-049D-46DD-AA65-D929A2953EE4Q46958514-C2CDEACD-4D1E-458E-8B08-34ABE835A374Q47194488-59E083CF-E7C0-477C-BF1A-896241AE56F6Q47254985-5DFC0AE9-92F3-4AF4-9C12-59F174E1F284Q47382142-D29A5345-16DD-4C3B-898E-313C2BB8B933Q47386188-D59321B6-D36F-4DF9-A60D-00516BEF65ADQ51284617-8D976483-9D7F-4AC4-BD80-6FBA07F4F09FQ51365621-55ABF968-B05F-4CC9-83D9-6DC7048399EDQ51439034-621F26AE-6965-4F49-B735-71D4B37D60E5Q51466164-58B4249C-3C4F-483D-8FE4-CBE86032B3D6Q51475245-0841F301-FAE1-48E0-8CAD-B2035577D755Q53033380-721D6C20-CD31-4547-8739-3A1A8D634809
P50
description
researcher, ORCID id # 0000-0002-5744-5129
@en
wetenschapper
@nl
name
Tianpei Hong
@ast
Tianpei Hong
@en
Tianpei Hong
@es
Tianpei Hong
@nl
type
label
Tianpei Hong
@ast
Tianpei Hong
@en
Tianpei Hong
@es
Tianpei Hong
@nl
prefLabel
Tianpei Hong
@ast
Tianpei Hong
@en
Tianpei Hong
@es
Tianpei Hong
@nl
P106
P31
P496
0000-0002-5744-5129